Dr Martin RobinsonDr Martin H Robinson MD, FRCP, FRCR

Reader in Clinical Oncology; Head of Academic Unit of Clinical Oncology and Lead for Radiotherapy Research, Academic Unit of Clinical Oncology, Weston Park Hospital
Tel: +44 (0)114 226 5212/5221 | Fax: +44 (0)114 226 5678/5364 | Email: m.h.robinson@sheffield.ac.uk

Link: www.shef.ac.uk/oncology/staffprofiles/robinson

Technical radiotherapy development and clinical trials

Martin is currently Reader and Honorary Consultant in Clinical Oncology at the Cancer Research Centre, Academic Unit of Clinical Oncology, Weston Park Hospital. He is also a Visiting Professor at Sheffield Hallam University. His research interests focus on technical radiotherapy development and clinical trials. His team is involved in research involving novel radiotherapy techniques such as intensity modulated radiotherapy and new imaging techniques such as PET scanning in head and neck cancer. He is Chief Investigator for the national radiotherapy study in sarcoma called VORTEX. He is also the Principal Investigator for several head and neck studies.

Martin is involved in teaching medical students both in clinics and as organiser of the Phase II Oncology Symposium. He also teach junior doctors at F1, F2 and Specialist Registrar level. Martin is a Consultant Clinical Oncologist at Weston Park Hospital and is responsible for the management of patients with head and neck cancer, sarcoma and lymphoma. He is involved in various head and neck and sarcoma trials and as the Chief Investigator for the VORTEX trial, he drives the first study ever designed to examine the accurate definition of radiotherapy target volumes in patients with adult extremity with soft tissue sarcomas. In addition, he is a local principal investigator in various other national and international trials.

Martin has authored many publications, and was the founding Editor for the journal `Sarcoma´, an international journal dedicated to multidisciplinary research into connective tissue oncology.

Selected publications:

1. Robinson, M, Murray, L (2011) Radiotherapy: technical aspects. Medicine. 36: 1, 9–14.
2. Lowry, L, Smith, P & Robinson, MH. (2011) Reduced dose Radiotherapy for local control in non-hodgkin lymphoma: A randomized phase III trial. Radiother Oncol. 100: 86–92.
3. Harrington, KJ, Berrier, A, Robinson, M et al (2010)
Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN).